← FDA DRUG APPROVALS

FDA NDA · NDA016829

DARVON-N W/ ASA

Sponsor: AAIPHARMA LLC

APPLICATION
NDA016829
TYPE
NDA
ORIGINAL APPROVAL
1971-09-09
LATEST ACTION
1986-10-16
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DARVON-N W/ ASADiscontinued
ASPIRIN 325MG, PROPOXYPHENE NAPSYLATE 100MG · CAPSULE · ORAL

Approval history

1986-10-16Labeling · Supplement 1 · standardAP
1971-09-09Type 4 - New Combination · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →